Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoadjuvant Operable Breast Cancer × Fluorouracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 225 Rectal Neoplasms 136 Colonic Neoplasms 109 Stomach Neoplasms 87 Pancreatic Neoplasms 82 Esophageal Neoplasms 69 Breast Neoplasms 65 Neoplasm Metastasis 48 Head and Neck Neoplasms 46 Squamous Cell Carcinoma of Head and Neck 45 Neoplasms 36 Adenocarcinoma Of Esophagus 32 Esophageal Squamous Cell Carcinoma 24 Adenocarcinoma 22 Carcinoma, Hepatocellular 13 Unspecified Adult Solid Tumor, Protocol Specific 12 Anus Neoplasms 11 Keratosis, Actinic 10 Gastrointestinal Neoplasms 10 Gallbladder Neoplasms 10 Biliary Tract Neoplasms 10 Urinary Bladder Neoplasms 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Nasopharyngeal Carcinoma 9 Liver Neoplasms 9 Bile Duct Neoplasms 9 Cholangiocarcinoma 8 Peritoneal Neoplasms 7 Carcinoma, Squamous Cell 7 Carcinoma, Renal Cell 7

Interventions

palbociclib 1 Letrozole 1 Fluorouracil 1 Epirubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02400567 2022-03-15

NeoPAL

UNICANCER

Phase 2 Completed

Neoadjuvant Operable Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡